The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population

Thyroid

Volumn 25, Issue 3, 2015, Pages 333-340

  Rogounovitch, Tatiana I ^a   Bychkov, Andrey ^a   Takahashi, Meiko ^b   Mitsutake, Norisato ^a   Nakashima, Masahiro ^a   Nikitski, Alyaksandr V ^a   Hayashi, Tomayoshi ^c   Hirokawa, Mitsuyoshi ^d   Ishigaki, Katsu ^e   Shigematsu, Kazuto ^f   Bogdanova, Tetiana ^g   Matsuse, Michiko ^a   Nishihara, Eijun ^d   Minami, Shigeki ^a   Yamanouchi, Kosho ^a   Ito, Masahiro ^h   Kawaguchi, Takahisa ^b   Kondo, Hisayoshi ^a   Takamura, Noboru ^a   Ito, Yasuhiro ^d   Miyauchi, Akira ^d   Matsuda, Fumihiko ^b   Yamashita, Shunichi ^a   Saenko, Vladimir A ^a   more..

^a NAGASAKI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d KUMA HOSPITAL   (Japan)

^e Ishigaki Clinic   (Japan)

^f Japanese Red Cross Nagasaki Atomic Bomb Hospital Nagasaki   (Japan)

^g V P Komisarenko Institute of Endocrinology and Metabolism of the Ukraine Academy of Medical Sciences   (Ukraine)

^h NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; PTCSC3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXE1; UNCLASSIFIED DRUG; NRG1 PROTEIN, HUMAN; PTCSC3 UNTRANSLATED RNA, HUMAN; UNTRANSLATED RNA;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CHROMOSOME 14Q; CHROMOSOME 14Q13.3; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID SURGERY; THYROID TUMOR; AGED; CHROMOSOME; CHROMOSOME MAP; COHORT ANALYSIS; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETICS; JAPAN; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; ULTRASTRUCTURE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHROMOSOME MAPPING; CHROMOSOMES; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEUREGULIN-1; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, UNTRANSLATED; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84924403466     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0431     Document Type: Article

References (29)

1. Kondo T, Ezzat S, Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292-306
2. Takami H, Ito Y, Okamoto T, Yoshida A 2011 Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg 35:111-121
3. Rosai J CM, DeLellis RA 1992 Tumors of the thyroid gland. In: Atlas of Tumor Pathology rs, fas 5. Armed Forces Institute of Pathology, Washington, DC, pp 21-48
4. Karga H, Lee JK, Vickery AL Jr, Thor A, Gaz RD, Jameson JL 1991 Ras oncogene mutations in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab 73:832-836
5. Shi YF, Zou MJ, Schmidt H, Juhasz F, Stensky V, Robb D, Farid NR 1991 High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Res 51:2690-2693
6. Vasko V, Ferrand M, Di Cristofaro J, Carayon P, Henry JF, De Micco C 2003 Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab 88:2745-2752
7. Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE 2003 Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 120:71-77
8. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE 2002 PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 26:1016-1023
9. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, De La Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464
10. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, Akulevich NM, Ratanajaraya C, Mitsutake N, Takamura N, Danilova LI, Lushchik ML, Demidchik YE, Heath S, Yamada R, Lathrop M, Matsuda F, Yamashita S 2010 The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19:2516-2523
11. Jendrzejewski J, He H, Radomska HS, Li W, Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R, De La Chapelle A 2012 The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci U S A 109:8646-8651
12. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, Jonasdottir A, Sigurdsson A, Stacey SN, Johannsdottir H, Helgadottir HT, Li W, Nagy R, Ringel MD, Kloos RT, De Visser MC, Plantinga TS, den Heijer M, Aguillo E, Panadero A, Prats E, Garcia-Castano A, De Juan A, Rivera F, Walters GB, Bjarnason H, Tryggvadottir L, Eyjolfsson GI, Bjornsdottir US, Holm H, Olafsson I, Kristjansson K, Kristvinsson H, Magnusson OT, Thorleifsson G, Gulcher JR, Kong A, Kiemeney LA, Jonsson T, Hjartarson H, Mayordomo JI, Netea-Maier RT, De La Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Rafnar T, Stefansson K 2012 Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet 44:319-322
13. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, Leskela S, Pita G, Milne R, Maravall J, Ramos I, Andia V, Rodriguez-Poyo P, Jara-Albarran A, Meoro A, del Peso C, Arribas L, Iglesias P, Caballero J, Serrano J, Pico A, Pomares F, Gimenez G, Lopez-Mondejar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodriguez-Antona C, Gonzalez-Neira A, Matias-Guiu X, Santisteban P, Robledo M 2009 The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5:e1000637
14. Bullock M, Duncan EL, O'neill C, Tacon L, Sywak M, Sidhu S, Delbridge L, Learoyd D, Robinson BG, Ludgate M, Clifton-Bligh RJ 2012 Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J Clin Endocrinol Metab 97:E1814-1819
15. Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T, Matyjasik J, Mierzejewski M, Medrek K, Oszutowska D, Suchy J, Gronwald J, Teodorczyk U, Huzarski T, Byrski T, Jakubowska A, Gorski B, Van De Wetering T, Walczak S, Narod SA, Lubinski J, Cybulski C 2008 A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 68:9982-9986
16. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S, Kere J, De La Chapelle A 2009 A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69:625-631
17. Jones AM, Howarth KM, Martin L, Gorman M, Mihai R, Moss L, Auton A, Lemon C, Mehanna H, Mohan H, Clarke SE, Wadsley J, Macias E, Coatesworth A, Beasley M, Roques T, Martin C, Ryan P, Gerrard G, Power D, Bremmer C, Tomlinson I, Carvajal-Carmona LG 2012 Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet 49:158-163
18. Matsuse M, Takahashi M, Mitsutake N, Nishihara E, Hirokawa M, Kawaguchi T, Rogounovitch T, Saenko V, Bychkov A, Suzuki K, Matsuo K, Tajima K, Miyauchi A, Yamada R, Matsuda F, Yamashita S 2011 The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet 48:645-648
19. Wang YL, Feng SH, Guo SC, Wei WJ, Li DS, Wang Y, Wang X, Wang ZY, Ma YY, Jin L, Ji QH, Wang JC 2013 Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. J Med Genet 50:689-695
20. DeLellis RA LR, Heitz PU, Eng C, eds. 2004 World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon
21. Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, Mitsutake N, Kominami R, Yamashita S 2009 Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer 16:491-503
22. Taga M, Eguchi H, Shinohara T, Takahashi K, Ito R, Yasui W, Nakachi K, Kusunoki Y, Hamatani K 2013 Improved PCR amplification for molecular analysis using DNA from long-term preserved formalin-fixed, paraffin- embedded lung cancer tissue specimens. Int J Clin Exp Pathol 6:76-79
23. Fagman H, Nilsson M 2011 Morphogenetics of early thyroid development. J Mol Endocrinol 46:R33-42
24. Hoshi S, Hoshi N, Okamoto M, Paiz J, Kusakabe T, Ward JM, Kimura S 2009 Role of NKX2-1 in N-bis(2-hydroxypropyl)-nitrosamine-induced thyroid adenoma in mice. Carcinogenesis 30:1614-1619
25. Liyanarachchi S, Wojcicka A, Li W, Czetwertynska M, Stachlewska E, Nagy R, Hoag K, Wen B, Ploski R, Ringel MD, Kozlowicz-Gudzinska I, Gierlikowski W, Jazdzewski K, He H, De La Chapelle A 2013 Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma. Thyroid 23:1532-1540
26. Montero-Conde C, Ruiz-Llorente S, Dominguez JM, Knauf JA, Viale A, Sherman EJ, Ryder M, Ghossein RA, Rosen N, Fagin JA 2013 Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas. Cancer Discov 3:520-533
27. Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R 2008 Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol 21:192-200
28. Zhang P, Zuo H, Nakamura Y, Nakamura M, Wakasa T, Kakudo K 2006 Immunohistochemical analysis of thyroidspecific transcription factors in thyroid tumors. Pathol Int 56:240-245
29. Bychkov A, Saenko V, Nakashima M, Mitsutake N, Rogounovitch T, Nikitski A, Orim F, Yamashita S 2013 Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry. Thyroid 23:817-828